Mihir Shivadatta Rajurkar

Title: Mihir Shivadatta Rajurkar: Innovator in Cancer Treatment

Introduction

Mihir Shivadatta Rajurkar is a notable inventor based in Worcester, MA (US). He has made significant contributions to the field of cancer treatment through his innovative research and patented methods. With a total of 2 patents, Rajurkar is recognized for his work in targeting specific genetic elements associated with cancer.

Latest Patents

Rajurkar's latest patents focus on the targeting of human satellite II (HSATII) for cancer treatment. His methods involve using sequence-specific agents, such as oligonucleotides, to treat cancers of epithelial origin. The research highlights that the heterochromatic HSATII satellite repeat is silenced in normal cells but is massively overexpressed in epithelial cancers and cancer cell lines when grown as xenografts or in 3D culture. The induction of HSATII RNA in these models suggests the presence of complementary DNA intermediates, paving the way for potential therapeutic applications.

Career Highlights

Throughout his career, Rajurkar has worked with esteemed institutions, including The General Hospital Corporation and Aalborg University. His research has contributed to advancements in understanding cancer biology and developing targeted therapies.

Collaborations

Rajurkar has collaborated with notable colleagues, including David T. Ting and Daniel Arie Haber. These partnerships have further enriched his research and innovation in the field of cancer treatment.

Conclusion

Mihir Shivadatta Rajurkar stands out as an influential inventor in the realm of cancer research. His innovative approaches and patented methods hold promise for improving treatment options for patients with epithelial cancers.